CPJE CLINICAL EXAM QUESTIONS AND ANSWERS 2024 - CALIFORNIAN PHARMACY JURISPRUDENCE
CPJE CLINICAL EXAM QUESTIONS AND ANSWERS 2024 - CALIFORNIAN PHARMACY JURISPRUDENCE A Pharmacist is dispensing new prescriptions for fosamprenavir, ritonavir, and truvada. In reviewing the patient's profile info, the pharmacist notes allergies to furosemide, glipizide, and bactrim. The pharmacist should call the physician to change: A. Truvada to combivir B. Fosamprenavir to Saquinavir C. Truvada to Atripla D. Fosamprenavir to tipranavir Correct Answer B A pharmacist is reviewing a patients medication profile prior to filling a new prescription for fentanyl transdermal patches. Which of the following presents a potential risk of interaction with fentanyl?
Geschreven voor
- Instelling
- CPJE - CALIFORNIAN PHARMACY JURISPRUDENCE
- Vak
- CPJE - CALIFORNIAN PHARMACY JURISPRUDENCE
Documentinformatie
- Geüpload op
- 31 januari 2024
- Aantal pagina's
- 30
- Geschreven in
- 2023/2024
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
- cpje clinical exam
-
cpje clinical exam questions and answers 2024
-
californian pharmacy jurisprudence exam 2024
-
californian pharmacy jurisprudence cpje exam
Ook beschikbaar in voordeelbundel